Skip to content
Ontario Rheumatology Association
  • Login
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory
  • Login
  • About
    • Overview
    • Organizational Priorities and Committees
    • Leadership
    • Annual Awards
  • Events
  • EAP & Limited Use Codes
    • Overview
    • Exceptional Access Program
    • EAP Forms and Downloads
    • Limited Use Codes
    • Biosimilar Fact Sheet
    • NIHB Drug List
    • MOHLTC IVIG Request Form
  • Informatics
    • Rheumatology EMR Database at ICES
  • Members
    • Overview
    • Member Directory
    • Peer Mentor Forum
    • Resource for Members
    • Become A Member
    • Renew Membership
    • Membership Perks
  • News
    • Overview
    • Drug Shortages Info
    • Newsletters
    • Other Publications
    • Info Hub
  • Contact
  • Directory

Drug Shortages

Denis Morrice • Edition: Fall 2017
Denis Morrice

Heads Up – Look out!

Drug Shortages are destined to get worse. Consider Teva the largest generic pharmaceutical manufacturer in the world is in the process of cutting 7,000 jobs and closing or selling 15 factories. Add to this the large number of mergers and acquisitions which of course impacts competition with consequences of higher prices and drug shortages.

This issue is incredibly serious when one considers that access to medication is just as important as access to Doctors and hospitals. There hasn’t been a public outcry simply because a drug shortage doesn’t affect everyone at the same time but instead an arthritis group one time, then an epilepsy group, then a cancer group, etc. The cost of drug shortages is quite staggering – imagine the time of professionals especially Doctors and Pharmacists as they deal with patients; the number of Federal, Provincial government committees, the number of hospital and LHINs committees – all trying to address the issue and yet no one group is responsible.

We obviously need a direct line to Ghostbusters!

Clearly a fresh look at regulations governing the pharmaceutical industry is needed. It has been noted that the FDA Drug Shortage website is quite comprehensive but is not the real solution.

In the meantime the ORA needs to establish a SWAT team that immediately addresses an arthritis drug shortage: notice to members, suggested alternative medication, engaging OPDP and CLHIA members in order to have immediate temporary access to the alternative medication that may not be on the public or private payer formulary list.

Denis Morrice
Executive Director, ORA

Other Articles in the Fall 2017 Newsletter

  • OMA Section on Rheumatology Report
  • McMaster Clinical Day in Rheumatology
  • Manpower & Third Party Payers
  • ORA 2017/2018 Membership Renewal
Editions
  • Winter 2021
  • Fall 2020
  • Summer 2020
  • Winter 2020
  • Winter 2019
  • Fall 2019
  • Spring 2019
  • Winter 2018
  • Fall 2018
  • Summer 2018
  • Summer 2017
  • Spring 2017
  • Fall 2017
  • Archive
  • Meet the Speakers: ORA 20th Annual Scientific Meeting
Committees
Communications Informatics Models of Care OMA
Tags
Biosimilar CSDTH Models of Care OBRI OMA pCPA SADIE

Contributors

The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.

Contributors
Ontario Rheumatology Association

© 2020 Ontario Rheumatology Association. All Rights Reserved. Website by Digital Chaos Inc.

  • About
  • Annual Awards
  • Events
  • EAP & Limited Use Codes
  • Exceptional Access Program
  • EAP Forms and Downloads
  • Limited Use Codes
  • Biosimilar Fact Sheet
  • NIHB Drug List
  • MOHLTC IVIG Request Form
  • Informatics
  • Members
  • Member Directory
  • Past Meeting Resources
  • Peer Mentor Forum
  • BecomeA Member
  • Renew Membership
  • News
  • Newsletters
  • Drug Shortages Info
  • Other Publications
  • Info Hub
  • Contact
  • Privacy